Symphony Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Symphony Asset Management’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-4,369	Closed	-$443K	–	437
2015 Q3	$443K	Buy	4,369 +2,204	+102%	+$262K	0.05%	333
2015 Q2	$269K	Sell	2,165 -3,341	-61%	-$403K	0.03%	357
2015 Q1	$651K	Buy	+5,506	New	+$622K	0.08%	266

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

TFA

Transamerica Financial Advisors St. Petersburg, Florida $1.17B AUM 23.36% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Symphony Asset Management's FBT Position: Q4 2015 in Review

Symphony Asset Management sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2015, closing a stake of 4,369 shares — an estimated $443K sold.

Symphony Asset Management first reported a position in FBT in Q1 2015 and held it in 3 quarters. The position peaked at $651K in Q1 2015. 129 funds tracked by Wall St. Rank hold FBT as of Q4 2015.

Symphony Asset Management reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2015 after selling out during the quarter.
Symphony Asset Management sold 4,369 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2015, an estimated $443K.
Symphony Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2015 and held it in 3 quarters.
Symphony Asset Management's First Trust NYSE Arca Biotechnology Index Fund position peaked at $651K in Q1 2015.
129 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2015.

Based on Symphony Asset Management's 13F filing for Q4 2015, filed 12 Feb 2016.